High prevalence of macrolide resistance: Not in every country! [Comment on: Halpern et al. J Antimicrob Chemother 2005; 55: 748-57] (multiple letters) [3]

Dominique L. Monnet, Christian T. Brandt, Margit S. Kaltoft, Line Bagger-Skjøt, Thomas L. Sørensen, Hans Ulrik K. Nielsen, Niels Frimodt-Møller, Michael T. Halpern, Jordana K. Schmier, Carl Asche, Phillip W. Sarocco, Lionel A. Mandell

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)433-435
Number of pages3
JournalJournal of Antimicrobial Chemotherapy
Volume56
Issue number2
DOIs
StatePublished - Aug 1 2005

Keywords

  • Antibiotic usage
  • Antimicrobial resistance surveillance
  • Macrolides
  • Streptococcus pneumoniae

ASJC Scopus subject areas

  • Pharmacology
  • Microbiology (medical)
  • Infectious Diseases
  • Pharmacology (medical)

Cite this

Monnet, D. L., Brandt, C. T., Kaltoft, M. S., Bagger-Skjøt, L., Sørensen, T. L., Nielsen, H. U. K., Frimodt-Møller, N., Halpern, M. T., Schmier, J. K., Asche, C., Sarocco, P. W., & Mandell, L. A. (2005). High prevalence of macrolide resistance: Not in every country! [Comment on: Halpern et al. J Antimicrob Chemother 2005; 55: 748-57] (multiple letters) [3]. Journal of Antimicrobial Chemotherapy, 56(2), 433-435. https://doi.org/10.1093/jac/dki215